Literature DB >> 16434235

Snake venom metalloproteases--structure and function of catalytic and disintegrin domains.

O H P Ramos1, H S Selistre-de-Araujo2.   

Abstract

Snake venoms are relevant sources of toxins that have evolved towards the engineering of highly active compounds. In the last years, research efforts have produced great advance in their understanding and uses. Metalloproteases with disintegrin domains are among the most abundant toxins in many Viperidae snake venoms. This review will focus on the structure, function and possible applications of the metalloprotease and disintegrin domains.

Mesh：

Substances：

Year:  2006        PMID： 16434235     DOI： 10.1016/j.cbpc.2005.11.005

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN： 1532-0456            Impact factor:   3.228


  35 in total

1.  Purification and characterization of a new weak hemorrhagic metalloproteinase BmHF-1 from Bothrops marajoensis snake venom.

Authors:  Frank Denis Torres-Huaco; Luis Alberto Ponce-Soto; Daniel Martins-de-Souza; Sergio Marangoni
Journal:  Protein J       Date:  2010-08       Impact factor: 2.371

2.  Systemic alterations induced by phospholipase A2 , BmooTX-I, isolated from Bothrops moojeni snake venom.

Authors:  Kellen Cristina Torres Costa; Bruna Barbosa de Sousa; Edigar Henrique Vaz Dias; Déborah Fernanda da Cunha Pereira; Mariana Santos Matias; Wilson Júnior Oliveira; Antônio Vicente Mundim; Carla Cristine Neves Mamede; Luíz Fernando Moreira Izidoro; Júnia de Oliveira Costa; Fábio de Oliveira
Journal:  Int J Exp Pathol       Date:  2018-11-20       Impact factor: 1.925

3.  Acurhagin-C, an ECD disintegrin, inhibits integrin alphavbeta3-mediated human endothelial cell functions by inducing apoptosis via caspase-3 activation.

Authors:  Wen-Jeng Wang
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion.

Authors:  Montamas Suntravat; Thomas J Helmke; Chairat Atphaisit; Esteban Cuevas; Sara E Lucena; Nestor L Uzcátegui; Elda E Sánchez; Alexis Rodriguez-Acosta
Journal:  Toxicon       Date:  2016-09-15       Impact factor: 3.033

Review 5.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

Review 6.  Snake venom disintegrins and cell migration.

Authors:  Heloisa S Selistre-de-Araujo; Carmen L S Pontes; Cyntia F Montenegro; Ana Carolina B M Martin
Journal:  Toxins (Basel)       Date:  2010-10-29       Impact factor: 4.546

7.  Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLA₂ inhibition.

Authors:  Juliana I Dos Santos; Fábio F Cardoso; Andreimar M Soares; Maeli Dal Pai Silva; Márcia Gallacci; Marcos R M Fontes
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

8.  P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.

Authors:  Giselle Pidde-Queiroz; Fábio Carlos Magnoli; Fernanda C V Portaro; Solange M T Serrano; Aline Soriano Lopes; Adriana Franco Paes Leme; Carmen W van den Berg; Denise V Tambourgi
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

9.  Bmoo FIBMP-I: A New Fibrinogenolytic Metalloproteinase from Bothrops moojeni Snake Venom.

Authors:  F S Torres; B Rates; M T R Gomes; C E Salas; A M C Pimenta; F Oliveira; M M Santoro; M E de Lima
Journal:  ISRN Toxicol       Date:  2012-11-04

Review 10.  Snake venom L-amino acid oxidases: trends in pharmacology and biochemistry.

Authors:  Luiz Fernando M Izidoro; Juliana C Sobrinho; Mirian M Mendes; Tássia R Costa; Amy N Grabner; Veridiana M Rodrigues; Saulo L da Silva; Fernando B Zanchi; Juliana P Zuliani; Carla F C Fernandes; Leonardo A Calderon; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.